Intellia Therapeutics Inc (NASDAQ:NTLA)

68.39
Delayed Data
As of 4:00pm ET
 -2.25 / -3.19%
Today’s Change
12.19
Today|||52-Week Range
92.00
+25.72%
Year-to-Date

Stock Price Forecast

The 14 analysts offering 12-month price forecasts for Intellia Therapeutics Inc have a median target of 80.00, with a high estimate of 111.00 and a low estimate of 22.00. The median estimate represents a +16.98% increase from the last price of 68.39.

Analyst Recommendations

The current consensus among 15 polled investment analysts is to Buy stock in Intellia Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.67
Sales
$8.6M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 3.34%
 
 
 
 
 
 
Growthannually -17.77%
 
 
 
 
 
 

Sales

Growthquarterly 29.98%
 
 
 
 
 
 
Growthannually -33.62%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.